DENAE HUDSON: Open Payments
NPI 1578325528 · ORONO, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 53 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,013 · 2025 $1,153
Food & beverage: $1,054Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $224 |
| Galderma Laboratories, L.P. | 8 | $195 |
| UCB, Inc. | 2 | $192 |
| ABBVIE INC. | 27 | $150 |
| Regeneron Healthcare Solutions, Inc. | 2 | $122 |
| Amgen Inc. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Organon LLC | 4 | $28 |
| Janssen Biotech, Inc. | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, SKYRIZI, OTEZLA, Rhapsido, VTAMA, TREMFYA.
Industry payments across ME — which companies pay providers there.
